Literature DB >> 3839956

The fate of 4-cyano-N,N-dimethylaniline in mice: the occurrence of a novel metabolite during N-demethylation of an aromatic amine.

C J Logan, D H Hutson, D Hesk.   

Abstract

4-Cyano-N,N-dimethylaniline (CDA), when administered as a single oral dose to mice (18.5 mg/kg), was rapidly absorbed and eliminated. The major route of elimination was the urine (78% dose in 24h). The residues in the tissues 48 h after dosing, as microgram equiv. of CDA/g, were: liver, 0.19; kidney, 0.10; testes, 0.01; fat, 0.10; blood, 0.02. The major metabolite was 2-amino-5-cyanophenyl sulphate, with the N-methyl analogue as a minor metabolite. A novel metabolite, N-acetyl-S-(4-cyanoanilinomethyl)cysteine, was also a significant urinary metabolite, indicating that an electrophilic intermediate is generated during the N-demethylation of CDA. The implications are that N-demethylation may have important toxicological consequences.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3839956     DOI: 10.3109/00498258509045009

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  1 in total

1.  Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan analogues as opioid receptor ligands.

Authors:  Yunyun Yuan; Saheem A Zaidi; David L Stevens; Krista L Scoggins; Philip D Mosier; Glen E Kellogg; William L Dewey; Dana E Selley; Yan Zhang
Journal:  Bioorg Med Chem       Date:  2015-03-06       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.